Product Details
Laridox-AQ DT++
Sulfadoxine; Pyrimethamine250mg; 12.5mg
Tablet
ROA
Oral
Applicant Name
IPCA Pharma Nigeria Limited
NRN
A4-101235
Status
Active
Composition
Each uncoated tablet contains: Sulfadoxine 250 mg, Pyrimethamine 12.5 mg Each uncoated tablet contains: Amodiaquine (as Hydrochloride) 76.5 mg Excipients q.s.
ATC Code/ATCvet Code
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
25 x (3+1)'s (in PVC-Alu blisters)
Product Description
Dispersible tablets LARIDOX-AQ DT(SULFADOXINE AND PYRIMETHAMINE DISPERSIBLE TABLETS(250MG/12.5MG) AND AMODIAQUINE DISPERSIBLE TABLETS 76.5MG) LARIDOX-AQ DT "(A)SULFADOXINE/PRIMETHAMINE 250MG/12.5MGDISPERSIBLE TABLETS, EXCIPIENTS ARE MICROCRYSTALLINE CELLULOSE, PREGELATINISED STARCH, COLLOIDAL SILICON DIOXIDE, CROPOVIDONE, POVIDONE, SUCRALOSE AND MAGNESIUM STEARATE (B) AMODIAQUINE (AS HYDROCHLORIDE) 76.5MG DISPERSIBLE TABLETS, EXCIPINETS ARE CROSCARMELLOSE SODIUM, MICROCRYSTALLINE CELLULOSE, POVIDONE,SUCRALOSE, SODIUM BICARBONATE,MAGNESIUM STEARATE.IT IS ESSENTIALLY SODIUM-FREE, IT CONTAINS LESS THAN 1 MMOL SODIUM(23MG) PER TABLET. " A4-101235 Drugs Imported Product 25*3+1 14-03-2025 IPCA PHARMA NIGERIA LIMITED, , OSOLO WAY AJAO ESTATE, LAGOS ISOLO LAGOS 08022389727 ipcapharma@yahoo.com "IPCA LABORATORIES LIMITED, PLOT NO 255/1 ATHAL SILVASSA PIN 396230(D&NH) INDIA
Manufacturer Name
IPCA Laboratories Ltd.
Manufacturer Country
INDIA
Approval Date
2025-04-30
Expiry Date
2030-04-29